Clinical Trials Logo

Total Hip Replacement Surgery clinical trials

View clinical trials related to Total Hip Replacement Surgery.

Filter by:
  • None
  • Page 1

NCT ID: NCT06342102 Not yet recruiting - Regional Anesthesia Clinical Trials

PENG and LFCN Block Versus FIC Block for Multimodal Analgesia After Total Hip Replacement Surgery: a Retrospective Analysis Focused on Movement (Retro-PvF)

Retro-PvF
Start date: March 26, 2024
Phase:
Study type: Observational

Total hip arthroplasty is a major surgical procedure performed on a growing number of patients. Optimal pain control with limited muscle weakness is paramount for a swift initiation of physical therapy and ambulation, thus expediting hospital discharge. Amongst the many peripheral nerve blocks, FIB (fascia iliaca block) has been recommended as the block of choice by many international guidelines since it offers the best pain control with a relatively low risk of motor block. PENG (pericapsular nerve group) and its association with LFCN (lateral femoral cutaneous nerve) has been proposed as an effective alternative that offers comparable, If not better, pain control with a considerably lower risk for motor block compared to FIB. Given the novelty of this block, there are few published papers on the subject, mostly case series or case reports thus justifying the need for retrospective study.

NCT ID: NCT05577936 Withdrawn - Clinical trials for Total Knee Replacement Surgery

Xperience™ vs Normal Saline Irrigation Solution for Decreasing Bioburden After Primary Total Hip and Knee Arthroplasty

Start date: March 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of Xperience, a no rinse antimicrobial solution, on joint infection rates in patients undergoing total hip (THA) and total knee (TKA) arthoplasty surgery.

NCT ID: NCT04245280 Recruiting - Postoperative Pain Clinical Trials

Effectiveness of PENG Block Combined to LFCN Block on the Quality of Recovery After Total Hip Replacement

PENG
Start date: May 4, 2021
Phase: N/A
Study type: Interventional

The main objective of this study is to evaluate the effectiveness of the association of PENG and LFCN blocks on the quality of recovery 24 hours after total hip replacement surgery.

NCT ID: NCT03666260 Completed - Clinical trials for Total Hip Replacement Surgery

Analgesia in Total Hip Arthroplasty by Quadratus Lumborum Block

ATHAQLuB
Start date: October 8, 2018
Phase: N/A
Study type: Interventional

Patients are painful after total hip arthroplasty. These patients have significant co-morbidities. Analgesics cause significant side effects in this population. Locoregional analgesia is therefore an effective means of reducing the consumption of opioids in this surgery. The "gold standard" of locoregional analgesia after Total Hip Arthroplasty is the femoral block. However, a new technique has recently been described: the Quadratus Lumborum Block. The comparison of these two techniques is lacking in the literature. The comparison of the Quadratus Lumborum Block to the femoral block in Total Hip arthroplasty is important in the analgesic strategy of patients undergoing this surgery.

NCT ID: NCT00771524 Completed - Clinical trials for Total Hip Replacement Surgery

Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone

Start date: April 2009
Phase: Phase 1
Study type: Interventional

This study is being performed to measure the amount of the antibiotic ceftobiprole (study drug) found in the bone and blood after receiving one dose prior to your elective hip replacement surgery. A piece of your hip bone which will be removed as part of your surgery will be analyzed to determine how much ceftobiprole gets into the bone.